CD274 (CD274 molecule)

2007-02-01  

Identity

HGNC
LOCATION
9p24.1
LOCUSID
ALIAS
B7-H,B7H1,PD-L1,PDCD1L1,PDCD1LG1,PDL1,hPD-L1
FUSION GENES

Other Information

Locus ID:

NCBI: 29126
MIM: 605402
HGNC: 17635
Ensembl: ENSG00000120217

Variants:

dbSNP: 29126
ClinVar: 29126
TCGA: ENSG00000120217
COSMIC: CD274

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000120217ENST00000381573Q9NZQ7
ENSG00000120217ENST00000381577Q9NZQ7

Expression (GTEx)

0
10
20
30
40
50
60

Pathways

PathwaySourceExternal ID
Cell adhesion molecules (CAMs)KEGGko04514
Cell adhesion molecules (CAMs)KEGGhsa04514
Immune SystemREACTOMER-HSA-168256
Adaptive Immune SystemREACTOMER-HSA-1280218
Costimulation by the CD28 familyREACTOMER-HSA-388841
PD-1 signalingREACTOMER-HSA-389948

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA166124615pembrolizumabChemicalLabelAnnotation, MultilinkAnnotationassociated26086854
PA166129522nivolumabChemicalLabelAnnotation, MultilinkAnnotationassociated26086854
PA166129523atezolizumabChemicalLabelAnnotationassociated
PA166157522rs113488022VariantLabelAnnotationassociated
PA166169875avelumabChemicalLabelAnnotationassociated
PA166169883durvalumabChemicalLabelAnnotationassociated

References

Pubmed IDYearTitleCitations
366500452024Expression and correlation of PD-L1 and HER2 in oesophageal squamous cell carcinoma.0
368550212024Influence of EGFR mutation status and PD-L1 expression in stage III unresectable non-small cell lung cancer treated with chemoradiation and consolidation durvalumab.2
371714822024Morphometric analysis of nuclear shape irregularity as a novel predictor of programmed death-ligand 1 expression in lung squamous cell carcinoma.0
374197942024The association between PD-1 / PD-L1 expression and clinicopathological features in sarcomatoid renal cell carcinoma.0
375538212024Apoptotic bodies inhibit inflammation by PDL1-PD1-mediated macrophage metabolic reprogramming.2
376140912024Clinicopathologic Evaluation of CD80, CD86, and PD-L1 Expressions with Immunohistochemical Methods in Malignant Melanoma Patients.0
376396812024Evaluation of programmed cell death ligand 1 expression in a contemporary cohort of penile squamous cell carcinoma and its correlation with clinicopathologic and survival parameters: A study of 134 patients.0
376884632024Elevated programmed cell death-1 protein/ligand (PD-1/PD-L1) and variants are associated with susceptibility to multiple myeloma: a case-control study in the Chinese cohort.0
376887672024Synergistic effects of BTN3A1, SHP2, CD274, and STAT3 gene polymorphisms on the risk of systemic lupus erythematosus: a multifactorial dimensional reduction analysis.1
376987362024N(6)-methyladenosine regulator YTHDF1 represses the CD8 + T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m(6)A/PD-L1 manner.6
377764432024PD-L1 Blockade Improves Survival in Sepsis by Reversing Monocyte Dysfunction and Immune Disorder.2
377926062024The levels of immunosuppressive checkpoint protein PD-L1 and tumor-infiltrating lymphocytes were integrated to reveal the glioma tumor microenvironment.0
377987542024Expression of B7-H3 and TIM-3 in gastric-type endocervical adenocarcinoma: prevalence, association with PD-L1 expression, and prognostic significance.0
378041642024Integrin α2 promotes immune escape in non-small-cell lung cancer by enhancing PD-L1 expression in exosomes to inhibit CD8 + T-cell activity.0
379373212024Expression of EGFR, PD-L1, and the mismatch repair proteins before and following therapy in malignant serous effusions with metastatic high-grade serous tubo-ovarian carcinoma.0

Citation

Dessen P

CD274 (CD274 molecule)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/46492